Kimia Biosciences Ltd Share Price

50.45
(0.40%)
Jul 23, 2024|03:40:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open50.5
  • Day's High50.5
  • 52 Wk High58.4
  • Prev. Close50.25
  • Day's Low48.25
  • 52 Wk Low31.99
  • Turnover (lac)1.09
  • P/E0
  • Face Value1
  • Book Value0.07
  • EPS0
  • Mkt. Cap (Cr.)238.69
  • Div. Yield0
No Records Found

Kimia Biosciences Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

50.5

Prev. Close

50.25

Turnover(Lac.)

1.09

Day's High

50.5

Day's Low

48.25

52 Week's High

58.4

52 Week's Low

31.99

Book Value

0.07

Face Value

1

Mkt Cap (₹ Cr.)

238.69

P/E

0

EPS

0

Divi. Yield

0

Kimia Biosciences Ltd Corporate Action

9 Sep 2023

12:00 AM

BookCloser

arrow

2 Sep 2023

12:00 AM

AGM

Announcement Date: 02 Sep, 2023

arrow

22 Jun 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Kimia Biosciences Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Kimia Biosciences Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|04:37 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 74.93%

Foreign: 0.00%

Indian: 74.93%

Non-Promoter- 0.38%

Institutions: 0.38%

Non-Institutions: 24.67%

Custodian: 0.00%

Share Price

Kimia Biosciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

4.73

4.73

4.73

4.64

Preference Capital

0

0

0

0.1

Reserves

0.73

10.16

13.71

8.64

Net Worth

5.46

14.89

18.44

13.38

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2017Mar-2016

Revenue

132.71

106.28

1.46

0.19

yoy growth (%)

24.86

7,179.88

660

-89

Raw materials

-96.85

-80.24

-0.35

-0.08

As % of sales

72.97

75.5

24.24

42.54

Employee costs

-14.09

-10.8

-0.83

-2.13

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2017Mar-2016

Profit before tax

5.53

1.22

-1

-4.04

Depreciation

-1.91

-1.66

-0.34

-0.29

Tax paid

-0.43

0.15

0.07

0

Working capital

5.9

31.91

-0.32

1.93

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2017Mar-2016

Growth matrix (%)

Revenue growth

24.86

7,179.88

660

-89

Op profit growth

88.23

-553.78

-70.97

76.22

EBIT growth

137.67

-609.74

-78.87

110.41

Net profit growth

269.61

-248.57

-77.06

138.02

View Ratios

No Record found

Kimia Biosciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,587.9

124.833,80,990.4867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,534.75

76.421,20,383.365310.662,259507.93

Cipla Ltd

CIPLA

1,489.7

32.381,20,295.961,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,154.4

33.791,16,159.651,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,769.25

26.361,12,931.21,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Kimia Biosciences Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Sameer Goel

Independent Director

Jagdeep Dhavvan

Independent Director

Richa Gupta

Director

Vipul Goel

Company Sec. & Compli. Officer

Lakshay Prakash

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The Company is engaged into the business of Pharamaceutical products.The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.95 to part-finance the project. Commercial production commenced in May 95. During the 1998-99, the company has become a sick industrial units.The Honble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking. .The Honble AAIFR disposed the appeal of M/s Ranbaxy Lab. Ltd vide its Order dated 30.08.2006, directing them to file an application before the Hoble BIFR only to redress grievances. Therefore, M/s Ranbaxy Lab. Ltd had filed an application-dated 31.10.06 before the Honble BIFR, requesting them to consider issuance of appropriate corrective orders. The Board has re-confirmed its earlier order. Therefore, despite negative net worth, the Company is out of BIFR purview.During the year 2017-18, the Scheme of Arrangement for Am
Read More

Company FAQs

What is the Kimia Biosciences Ltd share price today?

Down Arrow

The Kimia Biosciences Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹50.45 today.

What is the Market Cap of Kimia Biosciences Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kimia Biosciences Ltd is ₹238.69 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Kimia Biosciences Ltd?

Down Arrow

The PE and PB ratios of Kimia Biosciences Ltd is 0 and 717.67 as of 23 Jul ‘24

What is the 52 Week High and Low of Kimia Biosciences Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Kimia Biosciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kimia Biosciences Ltd is ₹31.99 and ₹58.4 as of 23 Jul ‘24

What is the CAGR of Kimia Biosciences Ltd?

Down Arrow

Kimia Biosciences Ltd's CAGR for 5 Years at 15.08%, 3 Years at 0.60%, 1 Year at 33.82%, 6 Month at 43.41%, 3 Month at -7.44% and 1 Month at -6.04%.

What is the shareholding pattern of Kimia Biosciences Ltd?

Down Arrow

The shareholding pattern of Kimia Biosciences Ltd is as follows:
Promoters - 74.94 %
Institutions - 0.38 %
Public - 24.68 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.